However, while PRT has been shown to reduce plasma IGF-1 [103] and increase IGFBP-3 [114] levels in prostate cancer, current epidemiological studies in cancer populations show significant heterogeneity in the response of the systemic IGF axis to exercise [118]. This evidence concerns the gene IGFBP3 and prostate cancer.